Skip to main content
Veterinary Medicines

Gabbrovet 70 70 mg/g Poeder voor toediening in het drinkwater/in de melk

Authorised
  • Paromomycin

Product identification

Medicine name:
Gabbrovet 70 70 mg/g Poeder voor toediening in het drinkwater/in de melk
Gabbrovet 70 70 mg/g Poudre pour administration dans le lait ou l'eau de boisson
Gabbrovet 70 70 mg/g Pulver zum Eingeben über das Trinkwasser/die Milch
Active substance:
  • Paromomycin
Target species:
  • Cattle (pre-ruminant)
  • Pig
Route of administration:
  • In drinking water/milk use
  • In drinking water use

Product details

Active substance and strength:
  • Paromomycin
    70.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (pre-ruminant)
      • Meat and offal
        20
        day
  • In drinking water use
    • Pig
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA06
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Gabbrovet 70 1 kg Jar Powder for use in drinking water/milk

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Unione Commerciale Lombarda S.p.A.
  • Ceva Vetem S.p.A.
Responsible authority:
  • FAMHP
Authorisation number:
  • BE-V131625
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."